On National Cellulite Day, 80% of Women Say Creams and Gadgets Don't Work¹

Tiger Aesthetics survey reveals widespread myths about cellulite, with only 7% of women knowing the real cause

CONSHOHOCKEN, Pa., Sept. 5, 2025 /PRNewswire/ -- On National Cellulite Day, Tiger Aesthetics is exposing the myths about cellulite, a common skin condition affecting up to 90% of women², yet only 7% know what primarily causes cellulite³.

The study reveals misconceptions about cellulite, including that it's primarily caused by poor diet and lack of exercise. In addition, the survey found nearly 80% of women state that creams and gadgets don't work over the long term⁴.

Cellulite appears on women with different weights, body types, fitness levels, and diets. It is an anatomical condition under the skin that appears when stiff, tough, fibrous bands between the skin and muscle pull on the skin to create dents, divots, and dimples². It cannot be solved with topical treatments, yet $3 billion is spent each year on cellulite creams and gadgets that don't work.

Tiger Aesthetics has developed the first and only cellulite treatment that allows a provider to identify and release the major underlying cause of cellulite and confirm the release in real time. Avéli^® is an FDA-cleared, minimally invasive treatment clinically shown in a 12-month observational study to deliver lasting reduction in cellulite on the buttocks and thighs in a single in-office procedure that takes about an hour with local numbing and little to no downtime^5,,6. 

The treatment is available in more than 700 aesthetic practices nationwide and has a ~90% RealSelf "worth it" rating⁷. Avéli^® also won the prestigious NewBeauty Award for "Best Minimally Invasive Cellulite Treatment" last year for the second year in a row.

"National Cellulite Day is about celebrating women feeling confident, radiant, and free in their bodies with and without cellulite" said Caroline Van Hove, President of Tiger Aesthetics. "Our national survey reveals that many women are needlessly spending thousands on creams and gadgets that simply don't work. With Avéli®, our goal is to share the truth about what really causes cellulite, encourage open conversations with providers when it becomes a concern, and deliver a solution that lives up to its promise."

Complete Survey Results

Of the women surveyed, 62% (1,565) identified themselves as having cellulite on their thighs and buttocks, and nearly a third said they have bought creams, lotions, or gadgets to try to get rid of it. The statistically significant findings reveal the following:

• Cellulite impacts daily life, including women's clothing choices, with 61% avoiding wearing shorts, swimsuits, or light-colored leggings due to their cellulite.
  
  
• More than 6 out of 10 (62%) believe the myth that lifestyle choices, such as poor diet and lack of exercise, primarily cause cellulite, resulting in women unnecessarily blaming themselves for the skin condition.
  
  
• 90% of women who bought creams, lotions, and gadgets to try to get rid of their cellulite have spent up to $1,000 looking for a solution.
  
  
• Nearly 80% of women who bought creams, lotions, and gadgets to try to get rid of their cellulite state they don't work over the long term.

See success stories on Avéli's YouTube Channel.

Methodology:

The omnibus survey was conducted in 2024 among 2,515 women aged 18+.

About Tiger Aesthetics Medical, LLC.
Tiger Aesthetics, headquartered in Conshohocken, PA, is committed to delivering new, cutting-edge products that meet the evolving needs of aesthetic practitioners and their patients. Built on a heritage of human cell & tissue processing expertise, Tiger Aesthetics enables practitioners to provide life-changing results for a wide range of patients, with treatment options from head-to-toe. These innovative technologies and products represent a unique opportunity for innovation to advance the field of Aesthetic Medicine.

Tiger Aesthetics' head-to-toe portfolio includes Sientra™ brand silicone gel breast implants, tissue expanders, the Avéli cellulite reduction device, Bellafill biostimulatory facial filler, Silhouette Instalift, PRP products, SimpliDerm hADM, and the Viality™ fat transfer system. In 2025, the Company will launch two innovative adipose cell and tissue products, alloClae and dermaClae, which will provide groundbreaking new treatment options for aesthetic practitioners and their patients. For more information, visit tiger-aesthetics.com.

References

¹ Full Omnibus Survey, conducted by YouGov on behalf of Avéli^®, available upon request. Total sample size was 4,901 adults, of whom 2,515 were women and 1,565 were women with lower body cellulite. Fieldwork was undertaken between August 20 and 26, 2024. The survey was carried out online. The figures have been weighted and are representative of all US adults (ages 18+).
² Emanuele E. Cellulite: advances in treatment: facts and controversies. Clin Dermatol. 2013;31(6):725-30.
³ Data on file, Revelle Aesthetics, Inc.
⁴ https://datahorizzonresearch.com/anti-cellulite-care-products-market-3149
⁵ Stevens WG, et al. Aesthet Surg J. 2022;42(8):937-945.
⁶ Stevens WG, et al. Aesthet Surg J. 2023;43(4):455-466.
⁷ RealSelf.com rating downloaded 8.27.24.

Media Contact:
Jennifer Avrhami
Pitch Public Relations
[email protected] 

SOURCE Tiger Aesthetics